Sensitivity of Mesothelioma Cells to PARP Inhibitors Is Not Dependent on BAP1 but Is Enhanced by Temozolomide in Cells With High-Schlafen 11 and Low-O6-methylguanine-DNA Methyltransferase Expression
Daniel Rathkey, Manakamana Khanal, Junko Murai, Jingli Zhang, Manjistha Sengupta, Qun Jiang, Betsy Morrow, Christine N. Evans, Raj Chari, Patricia Fetsch, Hye‐Jung Chung, Liqiang Xi, Mark J. Roth, Armando Filie, Mark Raffeld, Anish Thomas, Yves Pommier, Raffit Hassan
Topics & Concepts
TemozolomideMedicineMethyltransferasePoly ADP ribose polymeraseCancer researchDNA methyltransferaseMesotheliomaDNA repairDNAGlioblastomaPathologyBiochemistryBiologyMethylationPolymeraseOccupational and environmental lung diseasesDNA Repair MechanismsPARP inhibition in cancer therapy